Ozi bụ isi | |
Aha ngwaahịa | ceftriaxone sodium |
CAS Mba. | 74578-69-1 |
Ọdịdị | Na-acha ọcha na-acha ọcha ntụ ntụ |
Ọkwa | Ọkwa Pharma |
Nchekwa | 4ºC, chebe pụọ na ìhè |
Ndụ shelf | afọ 2 |
ngwugwu | 25kg/Drum |
Nkọwa ngwaahịa
Ceftriaxone bụ cephalosporin (SEF a low spor in) ọgwụ nje nke a na-eji na-agwọ ọnọdụ ndị dị ka ọrịa na-efe efe nke akụkụ okuku ume ala, akpụkpọ anụ na akpụkpọ anụ ahụ, ọrịa urinary tract, ọrịa pelvic inflammatory, nje septicemia, ọkpụkpụ na nkwonkwo ọrịa, na meningitis.
Iji ụlọ ọgwụ
Ceftriaxone sodium bụ β-lactamase-eguzogide ọgwụ cephalosporin nwere ogologo ndụ ọbara ọbara. Ihe abụọ na-enye aka na ogologo oge ọrụ nke ceftriaxone: njikọ protein dị elu na plasma na mwepụ nke ngwa ngwa. A na-ewepụ Ceftriaxone na bile na mmamịrị. Probenecid anaghị emetụta mpụta mmamịrị ya. N'agbanyeghị oke nkesa ya dị ala, ọ na-erute mmiri cerebrospinal na mkpokọta nke dị irè na meningitis. Ahụrụ ọgwụ pharmacokinetic na-adịghị n'ịntanetị.
Ceftriaxone nwere sistemu heterocyclic acid nke ukwuu na otu 3-thiomethyl. Ekwenyere na sistemụ mgbanaka dioxotriazine a na-adịghị ahụkebe na-enye ndị na-ahụ maka ọgwụ a pụrụ iche. Ejikọla Ceftriaxone na sonographically achọpụtara “sludge,” ma ọ bụ pseudolithiasis, na gallbladder na bile duct nkịtị. Mgbaàmà nke cholecystitis nwere ike ime n'ime ndị ọrịa nwere ike ime ya, ọkachasị ndị a na-eme ogologo oge ma ọ bụ nke dị elu na ọgwụgwọ ceftriaxone. Achọpụtara onye kpatara ya dị ka calcium chelate.
Ceftriaxone na-egosiputa mmetụta nje antibacterial sara mbara nke ukwuu megide ma gram-positive na gram-negativeorganisms. Ọ na-eguzogide nke ukwuu n'ọtụtụ chromosomal na plasmid-mediated β-lactamase. Ọrụ nke ceftriaxone megide Enterobacter, Citrobacter, Serratia, indole-positiveProteus, na Pseudomonas spp. na-adọrọ mmasị karịsịa. Ọ dịkwa irè na ọgwụgwọ nke ampicillin na-eguzogide gonorrheaand H. influenzae ọrịa ma n'ozuzu obere activation karịa cefotaxime megide Gram-positive bacteria na B.fragilis.